Cite

HARVARD Citation

    von Delft, A. et al. (2016). The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut. 65 (1), pp. 112-123. [Online]. 
  
Back to record